CHICAGO People who carry two copies of the APOE4 gene are virtually guaranteed to develop Alzheimer's and face symptoms at an earlier age, researchers reported on Monday (May 6) in a study that could redefine such carriers as having a new genetic form of the mind-wasting disease. The reclassification could change Alzheimer's research, diagnosis and approaches to treatment, according.